References
- Beesdo K, Knappe S, Pine DS. Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V. Psychiatr Clin North Am. 2009;32(3):483–524.
- Ezpeleta L, Keeler G, Erkanli A, et al. Epidemiology of psychiatric disability in childhood and adolescence. J Child Psychol Psychiatry. 2001;42(7):901–914.
- Hansen BH, Oerbeck B, Skirbekk B, et al. Non-obsessive-compulsive anxiety disorders in child and adolescent mental health services-are they underdiagnosed, and how accurate is referral information? Nord J Psychiatry. 2016;70(2):133–139.
- Connolly SD, Bernstein GA. Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry. 2007;46(2):267–283.
- Langley AK, Falk A, Peris T, et al. The child anxiety impact scale: examining parent- and child-reported impairment in child anxiety disorders. J Clin Child Adolesc Psychol. 2014;43(4):579–591.
- Pine DS, Helfinstein SM, Bar-Haim Y, et al. Challenges in developing novel treatments for childhood disorders: lessons from research on anxiety. Neuropsychopharmacology. 2009;34(1):213–228.
- Walkup JT, Albano AM, Piacentini J, et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med. 2008;359(26):2753–2766.
- Higa-McMillan CK, Francis SE, Rith-Najarian L, et al. Evidence base update: 50 years of research on treatment for child and adolescent anxiety. J Clin Child Adolesc Psychol. 2016;45(2):91–113.
- James AC, Reardon T, Soler A, et al. Cognitive behavioural therapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev. 2020;11:CD013162.
- Strawn JR, Welge JA, Wehry AM, et al. Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis. Depress Anxiety. 2015;32(3):149–157.
- Walter HJ, Bukstein OG, Abright AR, et al. Clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry. 2020; 59(10):1107–1124.
- Salanti G, Higgins JP, Ades AE, et al. Evaluation of networks of randomized trials. Stat Methods Med Res. 2008;17(3):279–301.
- Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004;23(20):3105–3124.
- Wang Z, Whiteside SPH, Sim L, et al. Comparative effectiveness and safety of cognitive behavioral therapy and pharmacotherapy for childhood anxiety disorders: a systematic review and meta-analysis. JAMA Pediatr. 2017;171(11):1049.
- Davis TE, Ollendick TH, Öst LG. One-Session treatment of specific phobias in children: recent developments and a systematic review. Annu Rev Clin Psychol. 2019;15:233–256.
- Silverman WK, Nelles WB. The anxiety disorders interview schedule for children. J Am Acad Child Adolesc Psychiatry. 1988;27(6):772–778.
- Johnson S, Barrett PM, Dadds MR, et al. The diagnostic interview schedule for children, adolescents, and parents: initial reliability and validity data. Behav Change. 1999;16(3):155–164.
- Guy W. ECDEU assessment manual for psychopharmacology. Washington (DC): Government Printing Office; 1976.
- Sigurvinsdóttir AL, Jensínudóttir KB, Baldvinsdóttir KD, et al. Effectiveness of cognitive behavioral therapy (CBT) for child and adolescent anxiety disorders across different CBT modalities and comparisons: a systematic review and meta-analysis. Nord J Psychiatry. 2020;74(3):168–180.
- Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. London: The Cochrane Collaboration; 2011.
- Socialstyrelsen . Nationella riktlinjer för vård vid depression och ångestsyndrom: Stöd för styrning och ledning [the swedish national clinical guidelines for anxiety- and affective disorders: Support for management and administration]. Stockholm: Socialstyrelsen; 2017.
- Sundhedsstyrelsen . Behandling af angst hos børn og unge: National klinisk retningslinje. Copenhagen: Sundhedsstyrelsen; 2019.
- Johnco C, McGuire JF, Roper T, et al. A meta-analysis of dropout rates from exposure with response prevention and pharmacological treatment for youth with obsessive compulsive disorder. Depress Anxiety. 2020;37(5):407–417.
- Walkup JT, Labellarte MJ, Riddle MA, et al. Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The research unit on pediatric psychopharmacology anxiety study group. N Engl J Med. 2001;344(17):1279–1285.
- Rynn MA, Walkup JT, Compton SN, et al. Child/adolescent anxiety multimodal study: evaluating safety. J Am Acad Child Adolesc Psychiatry. 2015;54(3):180–190.
- Luft MJ, Lamy M, DelBello MP, et al. Antidepressant-Induced activation in children and adolescents: risk, recognition and management. Curr Probl Pediatr Adolesc Health Care. 2018;48(2):50–62.
- Stewart E, Frank H, Benito K, et al. Exposure therapy practices and mechanism endorsement: a survey of specialty clinicians. Prof Psychol Res Pract. 2016;47(4):303–311.
- Kendall PC, Peterman JS. CBT for adolescents with anxiety: mature yet still developing. Am J Psychiatry. 2015;172(6):519–530.
- Whiteside SPH, Sattler AF, Hathaway J, et al. Use of evidence-based assessment for childhood anxiety disorders in community practice. J Anxiety Disord. 2016;39:65–70.
- Hipol LJ, Deacon BJ. Dissemination of evidence-based practices for anxiety disorders in Wyoming: a survey of practicing psychotherapists. Behav Modif. 2013;37(2):170–188.
- Konnopka A, Leichsenring F, Leibing E, et al. Cost-of-illness studies and cost-effectiveness analyses in anxiety disorders: a systematic review. J Affect Disord. 2009;114(1-3):14–31.
- Jolstedt M, Wahlund T, Lenhard F, et al. Efficacy and cost-effectiveness of therapist-guided internet cognitive behavioural therapy for paediatric anxiety disorders: a single-centre, single-blind, randomised controlled trial. Lancet Child Adolesc Health. 2018;2(11):792–801.
- Ginsburg GS, Kendall PC, Sakolsky D, et al. Remission after acute treatment in children and adolescents with anxiety disorders: findings from the CAMS. J Consult Clin Psychol. 2011;79(6):806–813.
- Piacentini J, Bennett S, Compton SN, et al. 24- and 36-week outcomes for the child/adolescent anxiety multimodal study (CAMS). J Am Acad Child Adolesc Psychiatry. 2014;53(3):297–310.
- Ginsburg GS, Becker-Haimes EM, Keeton C, et al. Results from the child/adolescent anxiety extended long-term study (CAMELS): primary anxiety outcomes. J Am Acad Child Adolesc Psychiatry. 2018;57(7):471–480.
- Hudson JL, McLellan LF, Eapen V, et al. Combining CBT and sertraline does not enhance outcomes for anxious youth: a double-blind randomised controlled trial. Psychol Med. 2021;31:1–9.
- Jakubovski E, Johnson JA, Nasir M, et al. Systematic review and meta-analysis: dose-response curve of SSRIs and SNRIs in anxiety disorders. Depress Anxiety. 2019;36(3):198–212.